Sucharita Mistry, PhD

Results from a randomized trial neither support nor rule out the possibility that aspirin might have a chemopreventive effect on melanoma incidence.

Researchers found that entry into the ventricle space during surgical resection elevated the risk of leptomeningeal disease in patients with melanoma brain metastases.

Stopping treatment after induction did not impact disease-free survival in patients with undetectable minimal residual disease.

Time to next treatment was significantly longer with brentuximab vedotin.

Most respondents said social determinants of health have a significant impact on their patients.

The mortality rate was significantly higher in the lockdown phase than in the lockdown-lifted phase.

For patients with low- or intermediate-risk disease, the risk of dying from CLL progression was similar to the risk of dying from CLL-related complications or from causes unrelated to CLL.

Editorialists questioned the quality of the data set.

The median overall survival was not reached at a median follow-up of 22.9 months.

Undetectable MRD was not associated with significantly better PFS at any time point.